Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending February 20, 2007. The report serves as a notification of transactions involving directors or persons discharging managerial responsibility, specifically regarding changes in interests in American Depositary Shares (ADSs).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is limited to a specific insider transaction notification and does not contain financial statements or performance metrics.
Material Changes
The only material change disclosed is a transaction by Mr. D. Phelan, a Person Discharging Managerial Responsibility. On February 16, 2007, he sold 19,721 ADSs from within the US Retirement Savings Plan at a price of $57.78 per ADS. The company was advised of this transaction on February 20, 2007.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document strictly adheres to the requirements of Disclosure Rule 3.1.4R(1)(a) regarding the notification of the specific share sale.
Key Facts for Investor Verification
- Transaction Type: Sale of 19,721 ADSs by Mr. D. Phelan.
- Transaction Date: February 16, 2007.
- Price per ADS: $57.78.
- Source of Shares: US Retirement Savings Plan.
- Notification Date: February 20, 2007.